InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+2.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Poirson Allen, Vice-Président Senior Marketing et Développement Corporatif. Officer active across 1 company, notably Cytek Biosciences, Inc.. Cumulatively, 13 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €22k. History available since 22 July 2021. The latest transaction was filed on 22 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Poirson Allen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
790 股Common StockSEC:0001415889-24-027366:0
790 股Common StockSEC:0001415889-24-021855:0
790 股Common StockSEC:0001415889-24-014149:0
3,338 股Common StockSEC:0001415889-24-007868:0
790 股Common StockSEC:0001415889-24-004881:0
790 股Common StockSEC:0001209191-23-056350:0
790 股Common StockSEC:0001209191-23-046827:0
790 股Common StockSEC:0001209191-23-031246:0
790 股Common StockSEC:0001209191-23-012357:0
790 股Common StockSEC:0001209191-22-058465:0
790 股Common StockSEC:0001209191-22-046948:0
1,053 股Common StockSEC:0001209191-22-031170:0
1,500 股@ US$17.00100.0% 占其流量Common StockSEC:0001209191-21-048386:0
标准退出：2021年10月20日 (T+90)
13 条申报中的 13 条
About Poirson Allen
Poirson Allen is Senior Vice President Marketing and Corporate Development at Cytek Biosciences, Inc. The 13 filings on record, all tied to Cytek Biosciences, Inc., cover the period from 2021-07-27 to 2024-11-20, with buys of EUR 21660 and no sell amount indicated in the sampled filings, and the most common transaction nature being option exercise.
